• An image of a hand spraying into a translucent face

    Researchers Develop Nasal Spray Treatment for Alzheimer’s Disease

    Innovative nasal spray treatment has shown promising results in clearing harmful tau protein build-up and improving cognitive function

    Read More
  • An image of a corona virus

    Study offers hope in fight against long covid

    Growth hormone injections significantly improved the neurologic symptoms of patients suffering from long COVID

    Read More
  • A woman's leg with deep blue veins

    Statins May Reduce Clotting Risks

    New findings could help providers better evaluate the risks of venous thromboembolisms for post-menopausal women on estrogen therapy

    Read More

UTMB News

An older man doing push ups on the sidewalk

New drug may help people stay strong as they age

Dr. Stanley Watowich discusses new research at the University of Texas Medical Branch holds promise for helping people maintain strength and mobility as they age.

a clipboard with a white piece of paper is in the foreground, blurry. a teen in a black hoody and jeans sits with his head hunched over and hands clasped, resting on his legs. a plant in a white pot is to the right. there's 2 blurry chairs in the BG

Research programs provide mental health resources for area youth

The Trauma Focused Cognitive Behavioral Therapy and Behavioral Activation programs are free and designed for eligible participants between the ages of eight and 20 who are not currently dealing with a mental health emergency such as psychosis or immediately suicidal thoughts.

UTMB Study Identifies an Anti-Aging Protein as Key to Preventing Vision Loss in Glaucoma

Researchers at the University of Texas Medical Branch recently made a breakthrough in understanding how aging contributes to glaucoma, the second leading cause of irreversible blindness worldwide. Their latest study published in Molecular Therapy highlights the crucial role of the anti-aging protein, Sirt6, for preventing vision loss in millions affected by the disease.

UTMB Awarded a $15.6 Million/year NIH Grant for Three Years of Vaccine Development with Partners

The University of Texas Medical Branch recently received a three-year award of $15.6 million per year from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) to conduct cutting-edge research aimed at developing vaccines and monoclonal antibodies (mAbs) to combat high-priority viral pathogens.

Categories